raxibacumab: Clinical Trials

3 trials of raxibacumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1
Phase 41Completed 1

Follow raxibacumab: new trials by email Literature Review of raxibacumab trials Research Report on raxibacumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
AVA, Raxibacumab, Diphenhydramine - Infections, Bacterial
Phase 4CompletedEmergent BioSolutions5732015-02-242024-03-18
A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects
placebo, raxibacumab - Healthy
Phase 3CompletedHuman Genome Sciences Inc.3222008-03-012018-11-15
An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection
Raxibacumab - Therapeutic Treatment of Inhalation Anthrax
Phase 2 / Phase 3CompletedHuman Genome Sciences Inc.202008-01-312018-11-29

Conditions studied

Bacterial Infections (1)

Sponsors

Human Genome Sciences Inc. (2)  ·  Emergent BioSolutions (1)

Countries

United States (1)

Results publications

PMID 19587338, PMID 32333847